期刊文献+

miR-143对肾癌GRC-1细胞增殖与凋亡及其靶点HIF-1α的影响 被引量:3

Effects of miR-143 on proliferation and apoptosis of renal cell carcinoma GRC-1 cells and its target HIF-1α
下载PDF
导出
摘要 目的探讨miR-143对肾癌GRC-1细胞增殖凋亡及其靶点缺氧诱导因子1α(HIF-1α)的影响。方法转染miR-143的模拟物于肾癌细胞株GRC-1细胞,采用实时定量PCR(q PCR)法检测转染的效果,根据实验将GRC-1细胞分为3组:未转染组、miR-143对照组和miR-143转染组,采用MTT法检测各组细胞的增殖情况,流式细胞术检测各组细胞凋亡情况;q PCR及Western blotting检测各组细胞的HIF-1αmRNA和蛋白水平;双荧光素酶报告基因实验验证miR-143与HIF-1α基因间的靶向关系。结果 miR-143转染组的miR-143水平高于未转染组和miR-143对照组,差异有统计学意义(P<0.05);与其余两组比较,miR-143转染组的增殖率降低而凋亡率升高,差异有统计学意义(P<0.05);瞬时过表达miR-143可降低GRC-1细胞的HIF-1αmRNA和蛋白水平(P<0.01),双荧光素酶报告基因实验证明HIF-1α是miR-143的直接作用靶点。结论miR-143可以调控肾癌GRC-1细胞的增殖凋亡,而HIF-1α是miR-143的直接靶点。 Objective To investigate the effects of miR-143 on proliferation and apoptosis of renal cell carcinoma GRC-1 cells and its target hypoxia inducible factor-1α (HIF-1α). Methods Renal cell carcinoma cell line GRC-1 cells were transfected with miR-143 mimics, and real time quantitative polymerase chain reaction (qPCR) was performed to evaluate the efficiency of transfection. According to the experiment, the GRC-1 cells were divided into 3 groups: non-transfection group, miR-143 control group and miR-143 transfection group. MTT method was used to detect the proliferation of cells in each group. Flow cytometry was used to detect the apop- tosis of each group. The qPCR and Western blotting were employed to measure the mRNA and protein level of HIF-1α. Dual luciferase reporter gene was applied to verify the relationship between miR-143 and HIF-1α. Results The level of miR-143 in miR-143 transfec- tion group was higher than those in non-transfection group and miR-143 control group, and the difference was statistically significant (P 〈0.05). Compared with other two groups, there were decreased proliferation rates but increased apoptotic rates in miR-143 transfection group (P〈0.05). Transient overexpression of miR-143 in GRC-1 cells decreased the expression of HIF-1α on both mRNA and protein levels. Moreover, dual-luciferase reporter assay confirmed that HIF-1α was a direct target of miR-143 in GRC-1 cells. Conclusion miR-143 may regulate the proliferation of GRC-I cells, and HIF-lct is a direct target of miR-143.
出处 《临床肿瘤学杂志》 CAS 2016年第11期967-971,共5页 Chinese Clinical Oncology
基金 溧阳科技局2014科技支撑(社会发展)资助项目(LC2014001)
关键词 肾癌 增殖 凋亡 双荧光素酶报告基因 MIR-143 缺氧诱导因子1Α Renal cell carcinoma Proliferation Apoptosis Dual luciferase reporter gene MiR-143 Hypoxia in- ducible factor-1α
  • 相关文献

参考文献6

二级参考文献71

  • 1郝朗松,王耕,钱昆,罗婷,李小军,伍晓汀.乳腺癌组织中缺氧诱导因子-1α的表达及其与肿瘤细胞增殖、血管形成的关系[J].四川大学学报(医学版),2007,38(1):60-63. 被引量:10
  • 2顾晓萌,卢雪峰,王慧,付金栋,季锐,姜大磊,雒燕.pAKT、HIF-1α在胃癌中的表达及与血管生成的关系[J].中国现代普通外科进展,2007,10(3):219-223. 被引量:4
  • 3Tomanek RJ,Schatteman GC.Angiogenesis:new insights and therapeutic potential.Anat Rec.2000.261:126-135. 被引量:1
  • 4Wiesener MS, Munchenhagen PM, Berger I, et al. Constitutive activation of hypoxia - inducible genes related to overexpression of hypoxia - inducible factor - 1 alpha in clear cell renal carcinoma [J]. Cancer Res, 2001,61(13) :5215 -5222. 被引量:1
  • 5Semenza GL. Targeting HIF - 1 for cancer therapy [ J ]. Nat Rev Cancer, 2003,3(10) :721 -732. 被引量:1
  • 6Kuijper A, van der Groep P, van der Wall E, et al. Expression hypoxia - inducible factor - 1 alpha and its downstream targets in fibroepithelial tumors of the breast [ J]. Breast Cancer Res, 2005, 7(5) :R808 - R818. 被引量:1
  • 7Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxia - inducible factor - 1 alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer [ J ]. Clin Cancer Res, 2003, 9 (6) : 2234 -2240. 被引量:1
  • 8Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases [J]. Cancer Res, 1999,59(22) :5830 -5835. 被引量:1
  • 9Ivanov S, Liao SY, Ivanova A, et al. Expression of hypoxia inducible cell - surface transmembrane carbonic anhydrases in human cancer [J]. Am J Pathol, 2001,158(3) : 905-919. 被引量:1
  • 10Costa LJ, Drabkin HA. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies [ J]. Oncologist, 2007,12(12) :1404 - 1415. 被引量:1

共引文献62

同被引文献21

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部